Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...

J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona ...

Leerink Partners analyst David Risinger has maintained their bullish stance on ANAB stock, giving a Buy rating yesterday. David Risinger has ...

A dividend aristocrat is an S&P 500 stock that has raised its dividend annually for at least 25 years. These are typically ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.

Plans for a game-changing rail link to Phuket are gathering steam—but officials are staying tight-lipped. Phang Nga Governor Supoj Rotreuang Na Nongkhai has just held a high-level meeting to review ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...